SDS 35042 Marathon IQ2 Comp A Euk GB
SDS 35042 Marathon IQ2 Comp A Euk GB
SDS 35042 Marathon IQ2 Comp A Euk GB
^(ValidationDate)
Yes
1
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 1/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 2/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 3/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
4.2 Most important symptoms and effects, both acute and delayed
There are no data available on the mixture itself. The mixture has been assessed following the conventional method
of the CLP Regulation (EC) No 1272/2008 and is classified for toxicological properties accordingly. See Sections 2
and 3 for details.
Exposure to component solvent vapour concentrations in excess of the stated occupational exposure limit may result
in adverse health effects such as mucous membrane and respiratory system irritation and adverse effects on the
kidneys, liver and central nervous system. Symptoms and signs include headache, dizziness, fatigue, muscular
weakness, drowsiness and, in extreme cases, loss of consciousness.
Solvents may cause some of the above effects by absorption through the skin. Repeated or prolonged contact with
the mixture may cause removal of natural fat from the skin, resulting in non-allergic contact dermatitis and absorption
through the skin.
If splashed in the eyes, the liquid may cause irritation and reversible damage.
This takes into account, where known, delayed and immediate effects and also chronic effects of components from
short-term and long-term exposure by oral, inhalation and dermal routes of exposure and eye contact.
Based on the properties of the epoxy constituent(s) and considering toxicological data on similar mixtures, this
mixture may be a skin sensitiser and an irritant. It contains low molecular weight epoxy constituents which are
irritating to eyes, mucous membrane and skin. Repeated skin contact may lead to irritation and to sensitisation,
possibly with cross-sensitisation to other epoxies. Skin contact with the mixture and exposure to spray mist and
vapour should be avoided.
Contains epoxy resin (MW ≤ 700), oxirane, 2,2'-[1,6-hexanediylbis(oxymethylene)]bis-. May produce an allergic
reaction.
Over-exposure signs/symptoms
Eye contact : Adverse symptoms may include the following:
pain or irritation
watering
redness
Inhalation : No specific data.
Skin contact : Adverse symptoms may include the following:
irritation
redness
Ingestion : No specific data.
4.3 Indication of any immediate medical attention and special treatment needed
Notes to physician : In case of inhalation of decomposition products in a fire, symptoms may be delayed.
The exposed person may need to be kept under medical surveillance for 48 hours.
Specific treatments : No specific treatment.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 4/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
6.2 Environmental : Avoid dispersal of spilt material and runoff and contact with soil, waterways, drains
precautions and sewers. Inform the relevant authorities if the product has caused environmental
pollution (sewers, waterways, soil or air). Water polluting material. May be harmful
to the environment if released in large quantities. Collect spillage.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 5/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 6/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 7/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 8/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
For right choice of glove materials, with focus on chemical resistance and time of penetration, seek advice by the
supplier of chemical resistant gloves.
The user must check that the final choice of type of glove selected for handling this product is the most
appropriate and takes into account the particular conditions of use, as included in the user's risk assessment.
Body protection : Personal protective equipment for the body should be selected based on the task
being performed and the risks involved and should be approved by a specialist
before handling this product.
Other skin protection : Appropriate footwear and any additional skin protection measures should be
selected based on the task being performed and the risks involved and should be
approved by a specialist before handling this product.
Respiratory protection : If workers are exposed to concentrations above the exposure limit, they must use a
respirator according to EN 140. Use respiratory mask with charcoal and dust filter
when spraying this product, according to EN 14387 (as filter combination A2-P2). In
confined spaces, use compressed-air or fresh-air respiratory equipment. When use
of roller or brush, consider use of charcoalfilter.
Environmental exposure : Do not allow to enter drains or watercourses.
controls
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 9/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 10/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Exposure to component solvent vapour concentrations in excess of the stated occupational exposure limit may result
in adverse health effects such as mucous membrane and respiratory system irritation and adverse effects on the
kidneys, liver and central nervous system. Symptoms and signs include headache, dizziness, fatigue, muscular
weakness, drowsiness and, in extreme cases, loss of consciousness.
Solvents may cause some of the above effects by absorption through the skin. Repeated or prolonged contact with
the mixture may cause removal of natural fat from the skin, resulting in non-allergic contact dermatitis and absorption
through the skin.
If splashed in the eyes, the liquid may cause irritation and reversible damage.
This takes into account, where known, delayed and immediate effects and also chronic effects of components from
short-term and long-term exposure by oral, inhalation and dermal routes of exposure and eye contact.
Based on the properties of the epoxy constituent(s) and considering toxicological data on similar mixtures, this
mixture may be a skin sensitiser and an irritant. It contains low molecular weight epoxy constituents which are
irritating to eyes, mucous membrane and skin. Repeated skin contact may lead to irritation and to sensitisation,
possibly with cross-sensitisation to other epoxies. Skin contact with the mixture and exposure to spray mist and
vapour should be avoided.
Contains epoxy resin (MW ≤ 700), oxirane, 2,2'-[1,6-hexanediylbis(oxymethylene)]bis-. May produce an allergic
reaction.
Acute toxicity
Product/ingredient name Result Species Dose Exposure
epoxy resin (MW ≤ 700) LD50 Dermal Rabbit 20 g/kg -
LD50 Oral Mouse 15600 mg/kg -
benzyl alcohol LD50 Oral Rat 1230 mg/kg -
Acute toxicity estimates
Product/ingredient name Oral (mg/ Dermal Inhalation Inhalation Inhalation
kg) (mg/kg) (gases) (vapours) (dusts
(ppm) (mg/l) and mists)
(mg/l)
Marathon IQ2 Comp A 100819.7 N/A N/A 901.6 N/A
benzyl alcohol 1230 N/A N/A 11 N/A
Irritation/Corrosion
Product/ingredient name Result Species Score Exposure Observation
epoxy resin (MW ≤ 700) Eyes - Severe irritant Rabbit - 24 hours 2 -
milligrams
Skin - Mild irritant Rabbit - 500 -
milligrams
titanium dioxide Skin - Mild irritant Human - 72 hours -
oxirane, 2,2'- Eyes - Mild irritant Mammal - - - -
[1,6-hexanediylbis species
(oxymethylene)]bis- unspecified
Skin - Mild irritant Mammal - - - -
species
unspecified
silane, trimethyoxy[3- Eyes - Irritant Mammal - - - -
(oxiranyl-methoxy)propyl]- species
unspecified
benzyl alcohol Eyes - Mild irritant Mammal - - - -
species
unspecified
Sensitisation
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 11/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
The mixture has been assessed following the summation method of the CLP Regulation (EC) No 1272/2008 and is
classified for eco-toxicological properties accordingly. See Sections 2 and 3 for details.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 12/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 13/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Packaging
Methods of disposal : The generation of waste should be avoided or minimised wherever possible. Waste
packaging should be recycled. Incineration or landfill should only be considered
when recycling is not feasible.
Type of packaging Waste catalogue
CEPE Guidelines 15 01 10* packaging containing residues of or contaminated by
hazardous substances
Special precautions : This material and its container must be disposed of in a safe way. Care should be
taken when handling emptied containers that have not been cleaned or rinsed out.
Empty containers or liners may retain some product residues. Avoid dispersal of
spilt material and runoff and contact with soil, waterways, drains and sewers.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 14/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 15/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 16/17
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon IQ2 Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 17/17